Conavi Medical Corp
XTSX:CNVI

Watchlist Manager
Conavi Medical Corp Logo
Conavi Medical Corp
XTSX:CNVI
Watchlist
Price: 0.355 CAD -4.05%
Market Cap: CA$27.2m

Conavi Medical Corp
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Conavi Medical Corp
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Conavi Medical Corp
XTSX:CNVI
Research & Development
-$15.3m
CAGR 3-Years
26%
CAGR 5-Years
-28%
CAGR 10-Years
6%
Profound Medical Corp
TSX:PRN
Research & Development
-$21m
CAGR 3-Years
-9%
CAGR 5-Years
-23%
CAGR 10-Years
-19%
Nanalysis Scientific Corp
XTSX:NSCI
Research & Development
-CA$472k
CAGR 3-Years
31%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theralase Technologies Inc
XTSX:TLT
Research & Development
-CA$2.6m
CAGR 3-Years
15%
CAGR 5-Years
N/A
CAGR 10-Years
2%
MedMira Inc
XTSX:MIR
Research & Development
-CA$965.6k
CAGR 3-Years
-43%
CAGR 5-Years
-34%
CAGR 10-Years
3%
O
Ondine Biomedical Inc
LSE:OBI
Research & Development
-CA$9.2m
CAGR 3-Years
-23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Conavi Medical Corp
Glance View

Market Cap
27.2m CAD
Industry
Health Care

Conavi Medical Corp is a CA-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Toronto, Ontario and currently employs 4 full-time employees. The company went IPO on 2008-04-28. Conavi Medical Corp., formerly Titan Medical Inc., is a Canada-based company. The firm is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. The Novasight Hybrid System is intended for intravascular imaging of coronary arteries and is indicated in patients who are candidates for transluminal interventional procedures. Its Novasight Hybrid System combines both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries. Hybrid IVUS and OCT imaging provides additional information over single modality imaging in complex lesions. The versatility of hybrid imaging is useful for a variety of complex percutaneous coronary intervention (PCIs), including situations where the customer may want to image large ostial lesions with IVUS but also use OCT for diseased distal lesions and/or stent assessment.

CNVI Intrinsic Value
HIDDEN
Show

See Also

What is Conavi Medical Corp's Research & Development?
Research & Development
-15.3m USD

Based on the financial report for Sep 30, 2025, Conavi Medical Corp's Research & Development amounts to -15.3m USD.

What is Conavi Medical Corp's Research & Development growth rate?
Research & Development CAGR 10Y
6%

The average annual Research & Development growth rates for Conavi Medical Corp have been 26% over the past three years , -28% over the past five years , and 6% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett